A systematic determination of a subject's merit, worth and significance,
POPULARITY
Categories
150 episodes with Evaluation
252 episodes with Evaluation
182 episodes with Evaluation
180 episodes with Evaluation
180 episodes with Evaluation
169 episodes with Evaluation
90 episodes with Evaluation
34 episodes with Evaluation
32 episodes with Evaluation
48 episodes with Evaluation
25 episodes with Evaluation
24 episodes with Evaluation
37 episodes with Evaluation
55 episodes with Evaluation
30 episodes with Evaluation
32 episodes with Evaluation
22 episodes with Evaluation
17 episodes with Evaluation
21 episodes with Evaluation
22 episodes with Evaluation
26 episodes with Evaluation
25 episodes with Evaluation
31 episodes with Evaluation
45 episodes with Evaluation
16 episodes with Evaluation
32 episodes with Evaluation
17 episodes with Evaluation
17 episodes with Evaluation
23 episodes with Evaluation
18 episodes with Evaluation
16 episodes with Evaluation
15 episodes with Evaluation
33 episodes with Evaluation
17 episodes with Evaluation
19 episodes with Evaluation
10 episodes with Evaluation
12 episodes with Evaluation
12 episodes with Evaluation
23 episodes with Evaluation
16 episodes with Evaluation
12 episodes with Evaluation
27 episodes with Evaluation
13 episodes with Evaluation
14 episodes with Evaluation
8 episodes with Evaluation
17 episodes with Evaluation
16 episodes with Evaluation
14 episodes with Evaluation
10 episodes with Evaluation
11 episodes with Evaluation
17 episodes with Evaluation
9 episodes with Evaluation
9 episodes with Evaluation
12 episodes with Evaluation
When is it time to move from repeat drainage to a tunneled catheter for managing pleural effusions or ascites? On this episode of BackTable Podcast, Dr. Neil Jain interviews Dr. Marco Ertreo, interventional radiologist and IR residency program director at Strong Memorial Hospital, University of Rochester, about best practices for tunneled catheter management in both the chest and abdomen. They discuss the triggers for placing a tunneled catheter, patient selection, placement technique, home drainage protocols, complication management, and the unique considerations for malignant versus cirrhotic ascites. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction06:39 - Indications and Pleural Catheter Placement Technique12:10 - Tunneling, Cuff Position and Exit Site Selection17:42 - Home Drainage, Volume Limits and Complications26:13 - Peritoneal Catheters, TIPS Candidacy and Catheter Choice35:16 - Avoiding Bowel and Varices43:42 - Key Takeaways and Closing Remarks --- More about this episode Dr. Ertreo shares practical details about pocket selection, access points, catheter testing, and choosing Tenckhoff catheters for abdominal cases to avoid proprietary systems. The conversation covers volume limits, complication counseling, criteria for removal, and the psychological impact of living with a long-term drain. They discuss when to consider TIPS for cirrhotic patients, the importance of early conversations with patients and referring providers, and why multidisciplinary teamwork and family support are essential for long-term success. --- Resources Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trialhttps://pubmed.ncbi.nlm.nih.gov/30037711/ Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guidelinehttps://www.atsjournals.org/doi/10.1164/rccm.201807-1415ST Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions, Part II: Recommendationshttps://pubmed.ncbi.nlm.nih.gov/31229333/ Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (AASLD)https://pubmed.ncbi.nlm.nih.gov/33942342/ --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Tobin and Leroy breakdown the Dolphins' daunting Week 2 matchup as heavy underdogs against the 49ers. They debate whether the team should focus on rookie development for Malik Willis or lean heavily on Devon Achane to stay competitive. (00:01:00) Tobin and Leroy Intro (00:01:16) Dolphins vs 49ers Preview (00:03:42) Evaluation of Rookies (00:08:23) NFL Injury Updates (00:12:50) 49ers Defensive Mismatches
Brady talks with former Seattle Mariners infielder and current team broadcaster Ryon Healy about the internal conversations for players at the end of a season, how accountability is achieved in 2026, leadership styles and the M's clubhouse and more, including the work of MLB hitting coaches. The Mariners are 72-81 with nine games left. To explore coverage, visit aspcapetinsurance.com/FOUL. The ASPCA® is not an insurer and is not engaged in the business of insurance. Calling all Mariners fans: Refuse to Lose Territory is your new home for Mariners analysis all year round. Subscribe on Youtube today. Part of the Foul Territory Network.See omnystudio.com/listener for privacy information.
Welcome back to "First Draft." Mike Greenberg, Field Yates and Mel Kiper Jr. break down major draft-evaluation games from Week 2 of the 2026 college football regular season. #ESPN #ncaa #firstdraft #nfl #nfldraft #sports (0:00) Welcome to "First Draft" (1:56) Oklahoma State QB Drew Mestemaker (4:12) Texas QB Arch Manning (8:28) Ohio State WR Jeremiah Smith (11:39) Texas WRs Cam Coleman & Ryan Wingo (15:11) Oregon QB Dante Moore (18:00) QBs Darian Mensah & Lincoln Kienholz (22:08) Orange Crushers of the Week (25:05) Final thoughts! #ESPN #ncaa #firstdraft #nfl #nfldraft #sports Learn more about your ad choices. Visit podcastchoices.com/adchoices
In part two of this two-part conversation, Dr. Scott Jones returns with Steve Shanley and Alan Feirer to apply the idea of teaching for independence to the most practical – and often most emotional – parts of the job: grading, evaluation, and repertoire selection. Building on Part 1's skill buckets and culture work, this episode explores: What grades should represent in a performance-based class Rethinking points for attendance, bringing an instrument, and “showing up” Aligning evaluation with the individual skills that lead to independence How a focus on independence can shape repertoire choice and long-term planning Scott also shares how he has wrestled with these questions over his career and how his current grading approach reflects what he most wants students to learn and become as musicians. Become an Insider for ad-free episodes, early releases, bonus content, and more! https://musicedinsights.supercast.com/
A new study reveals a critical vulnerability window during pregnancy when cell phone radiation can cause lasting brain damage in developing offspring. Researchers exposed pregnant rats to nine hundred megahertz EMF radiation -- the same frequency range as cell phones -- during different stages of pregnancy. They found that exposure during the final week of pregnancy caused significant brain cell death in the hippocampus, the brain region critical for learning and memory. This timing coincides with a crucial period when new neurons are forming. I'm R Blank, and in this episode, we break down what this means for expectant mothers and why the timing of EMF exposure during pregnancy matters more than you might think. In This Episode Why late pregnancy represents a critical vulnerability window for EMF exposure The specific molecular pathways that lead to brain cell death in developing offspring What this animal research suggests about human pregnancy and cell phone use One practical step pregnant women can take today Featured Study Read the full study: An Evaluation of Neuronal PARP-1 and Caspase-3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages See all studies at shieldyourbody.com/research
We wrap up Mary's first year with the podcast, and changes are afoot for our upcoming season, but why? Let's explore to the point of physical discomfort! We act out an odd annual employee review, a dramatic pitch for a new play, and the navel-gazing club. Hear more at philosophyimprov.com. Support the podcast and listen ad-free at patreon.com/philosophyimprov.
Card evaluation is one of the most (if not the most) important skills for being a good limited player! Join me as we talk about how to improve your card evaluation skills and the traps to avoid along the way Limited Level-Ups Patreon: https://www.patreon.com/limitedlevelups LLU Tierlist: https://limitedlevelups.com/tier-list TCGplayer: https://partner.tcgplayer.com/level-ups Limited Level-Ups Discord: bit.ly/jointhedischord Alex's Stream: https://www.twitch.tv/chord_o_calls Limited Level-Ups Podcast:https://limitedlevelups.libsyn.com/ Alex's Coaching Email: chordocoach@gmail.com UntappedGG Affiliate Link (download today! It helps the channel) : https://mtga.untapped.gg/companion?utm_medium=affiliate&utm_campaign=chordocalls
Aging science has gotten much better at describing who appears to be aging faster or slower. What medicine still lacks is a reliable feedback loop: a way to tell whether something we do is actually changing the biology that drives age-related disease.Dr. Nir Barzilai argues that solving that measurement problem could turn geroscience from an interesting field of research into something doctors can actually use: measure where you are, intervene, measure again, and learn what works.Free course: Improve your metabolic healthGet our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: https://levels.link/wnlWhat We Cover:What centenarians reveal about living longer and spending less time sickWhy changing one hallmark of aging can affect several othersHow TAME was designed to test metformin as an anti-aging drug and to convince the FDA to treat aging itself as an endpoint—and why it failed to get off the groundWhy metformin, SGLT2 inhibitors, GLP-1 agonists, and some osteoporosis drugs are being studied as potential gerotherapeutics, or anti-aging drugsHow FAST is searching existing clinical trials for biomarkers that change when an intervention affects aging biologyWhether aging needs continuous monitoring or can be meaningfully tracked a few times a year
Tired of ADHD strategies that don't work? Start with my this training: Stop Trying to “Fix” Your ADHD. You're Not Broken: https://programs.tracyotsuka.com/sign-up_____Dr. Ann Bennett has spent more than 20 years studying what helps people learn, adapt, and thrive. So when she decided to look at what ADHD podcasts were actually doing for women, she was not expecting the results to be THIS strong.Dr. Bennett leads Applied Research & Evaluation at Understood.org and identifies as disabled, autistic, and AuDHD. In a first-of-its-kind study with Torrens University Australia, she and her research partner looked at how podcasts hosted by and for women with ADHD affect self-perception, health literacy, relationships, and hope for the future.What they found was bigger than “podcasts are helpful.”Women were moving from “something is wrong with me” to “I am a woman with ADHD, and I can navigate this.” About 85 to 86 percent reported a stronger sense of hope for their future, and the benefits showed up across every dimension of thriving the researchers measured.In this episode, Tracy and Ann talk about why lived experience matters as much as credentials, why being talked with feels different from being talked at, what clinicians could learn from podcasts, and why hearing another woman say “me too” can genuinely change the way you see yourself.Resources:Website: https://www.understood.org/en/people/ann-m-bennettLinkedIn: https://www.linkedin.com/in/dr-annbennettTEDx Talk: https://www.youtube.com/watch?reload=9&v=noZM8CRmrBoPodcast Study: https://www.understood.org/en/research-and-surveys/the-power-of-podcasts-how-podcasts-are-supporting-women-with-adhdSend a Message: Your Name | Email | Message Explore more from me:
The ACOG PB 222 states, “In women with preeclampsia with severe features at less than 34 0/7 weeks of gestation, with stable maternal and fetal condition, expectant management may be considered”. The expectant management of preeclampsia with severe features before 34 0/7 weeks of gestation is based on strict selection criteria of those appropriate candidates and is best accomplished in a setting with resources appropriate for maternal and neonatal care. BOX 4 in that ACOG guidance lists “Conditions Precluding Expectant management”, with one of the conditions being “Uncontrolled severe-range blood pressures (persistent systolic blood pressure 160 mm Hg or more or diastolic blood pressure 110 mm Hg or more not responsive to antihypertensive medication” (i.,e. persistent and refractory to appropriate medication). But what defines “uncontrolled hypertension”? When is preterm delivery indicated based on that feature? In this episode, we will answer this real-world clinical question. So, for a patient who is otherwise stable, asymptomatic, without HELLP syndrome, whose fetus is stable but is under 34 weeks, when can “uncontrolled hypertension” be diagnosed to prompt delivery? Listen in for details as we highlight the 2022 SMFM Special Report on that matter. 1. ACOG PB 2222. SMFM Special report: Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation, Nov 20223. De Backer J, Haugaa KH, Hasselberg NE, et al. 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy. European Heart Journal. 20254. SOGC Clinical Practice Guideline: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary; No. 307, May 20145. ISSHP (2018): The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Preg Hypertension. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/http://www.isshp.org/wp-content/uploads/2018/06/1-s2.0-S2210778918301260-main.pdf
Send us Fan MailBleeding that feels “off” is easy to downplay until it derails your life or shows up after menopause. We revisit our conversation with women's health nurse practitioner Kelsey Kennedy and layer in what's changed since then, including newer ACOG guidance that supports a more proactive approach to postmenopausal bleeding. The key message is simple: a reassuring pelvic ultrasound alone is not always enough, because high grade endometrial cancer can occur even with a thin lining. Kelsey and Dr. Thacker walk through what abnormal uterine bleeding actually means in real life, from irregular cycles and spotting between periods to heavy flow that soaks pads, clothes, and sheets. Then they sort the most common causes including fibroids, endometrial polyps, adenomyosis, and endometriosis, and we explain why minimally invasive gynecologic surgery (MIGS) teams can be so valuable when surgery is on the table or when prior care has not found the answer. They also highlight an often missed angle: some abnormal bleeding is driven by bleeding disorders like von Willebrand disease, not just gynecologic anatomy or hormones.Support the show
Uncontrolled and resistant hypertension is more common than we think. In the second episode of this special three-part series, Dr. Neil Skolnik discusses management strategies, but also explores our new understanding of aldosterone and its stealth role in hypertension. This series is supported with support from AstraZeneca. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to DOC Updates via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Payal Kohli, MD, Harvard-educated preventive cardiologist and the Founder and Medical Director of Cherry Creek Heart in Aurora Colorado, Associate Adjunct Professor in Cardiology at Johns Hopkins University, and Associate Adjunct Professor in Cardiology at Duke University Selected references: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee. Hypertension 2025; 82(10) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957 Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. N Engl J Med 2025;393:1363-74. DOI: 10.1056/NEJMoa2507109 Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 2025, 00, 1–43 https://doi.org/10.1210/clinem/dgaf284 A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015;373:2103-2116
With more than 25 years of experience across real-time machine learning, distributed computing, high-availability systems, and enterprise AI, Ravi brings a deeply technical perspective to one of the biggest questions facing organizations today: How do we move AI agents from impressive demos to systems businesses can actually trust to do work?We explore how enterprises can operationalize AI agents, why industrial systems of record are critical to agentic applications, and what organizations need to consider around context, security, evaluation, governance, and human oversight.Key Highlights:Agentic AI: Hype vs. Reality: Where enterprise AI agents are delivering value today — and where vendor promises are still ahead of what's realistically achievable.From Copilots to AI Workers: What separates a conversational AI assistant from an agent capable of reasoning, taking action, and participating in real enterprise workflows.Agents + Systems of Record: Why integrating AI agents with ERP and other operational systems is essential for reliable, context-aware decision-making.Engineering for Reliability: Lessons from distributed computing, real-time analytics, and high-availability systems that today's agentic AI teams can't afford to ignore.Security, Evaluation & Guardrails: How enterprises should approach permissions, observability, failure detection, governance, and human oversight as AI systems become increasingly autonomous.
A new study reveals a critical vulnerability window during pregnancy when cell phone radiation exposure can cause lasting brain damage in developing offspring. Researchers exposed pregnant rats to nine hundred megahertz EMF radiation -- the same frequency range as cell phones -- during different stages of pregnancy. They discovered that exposure timing matters profoundly. Radiation during the final week of pregnancy triggered significant brain cell death in the hippocampus, the region critical for learning and memory. Earlier exposure showed no such damage. This timing coincides with a crucial period when new neurons are forming in the developing brain. In This Episode Why the final trimester represents a critical vulnerability window for EMF exposure The specific molecular pathways that lead to brain cell death in developing offspring What this means for pregnant women using wireless devices Simple, practical steps to reduce prenatal EMF exposure Featured Study Read the full study: An Evaluation of Neuronal PARP-1 and Caspase-3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages See all studies at shieldyourbody.com/research
Dr Jairo H. Migueles studied Physical Activity and Sport Sciences (2009-2013) and a Research Master in Physical Activity and Sport at the University of Granada (2014-2015). He is currently doing his doctoral thesis at the University of Granada with the ActiveBrains project (effects of a randomized controlled exercise program on cognition, mental and physical health in overweight and obese preadolescents). His main areas of interest are: Evaluation of physical activity, energy expenditure and sleep objectively through accelerometry. Assessment of physical fitness in young population Study of the effects of physical activity, physical exercise and sleep on different dimensions of physical, mental, cognition and brain health in young people. Physical exercise interventions through the use of mobile phones (SmartPhones), which today is known as m-Health ____________________ This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS --- SB and PA measurements, analysis, and feedback made easy. Learn more about Fibion Research --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Collect self-report physical activity data easily and cost-effectively with Mimove. --- Explore our Wearables, Experience sampling method (ESM), Sleep, Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow Fibion on Twitter https://twitter.com/fibion https://www.youtube.com/@PA_Researcher
Evaluation speech - Speech in TT group Evaluation speech - Spotify podcast#evaluation #member #nagendrabharathi #speechMy Poems/Stories/Articles in Tamil and English are available at https://www.amazon.com/author/nagendrabharathi
Sales doesn't start when you make an offer. It starts long before that.In this episode of The Estherpreneur Podcast, I unpack what most entrepreneurs overlook: the internal journey every buyer goes through before they ever say yes.Not everyone is ready to buy today, and treating them like they are can actually push them further away.This conversation explores how understanding that process changes everything—from how you communicate to how you lead people through decisions without pressure or manipulation.If you're a CEO, consultant, or founder who wants to sell with integrity and consistency, this episode will give you a deeper lens into how people actually make decisions.The Estherpreneur Podcast is for CEOs, founders, and faith-driven entrepreneurs who are growing—but something feels misaligned. Whether it's your structure, your clarity, or your capacity, this show helps you identify what's off and what to focus on next.Hosted by Edna Harding, author of "The Ugly Side of Sales 2.0" and founder of Favor & Wealth, a business growth strategy firm that helps leaders scale with clarity, structure, and biblical alignment.
Season 5, episode 6 of Just Us: Before, Birth, and Beyond features two members of the Project CARA team who implement and operationalize the contingency management (CM) program at MAHEC in a perinatal setting. This is an effective, evidence-based treatment for substance use disorder that is based on positive reinforcement throughout recovery. Despite its proven efficacy, implementing CM can come with logistical challenges and barriers. Listen in to learn how Project CARA navigated these in designing their own CM program to provide optimal, patient-centered care. Key ResourcesJones, H. E., et al. (2012). Voucher-based contingency management improves outcomes in substance use treatment. Journal of Substance Abuse Treatment, 43(3), 267–274.Festinger, D. S., Dugosh, K. L., Kirby, K. C., & Seymour, B. L. (2014). Contingency management for cocaine treatment: Cash vs. vouchers. Journal of Substance Abuse Treatment, 47(2), 168–174. SAMHSA. (2025). Contingency management for the treatment of substance use disorders: Advisory. U.S. Department of Health and Human Services.Rash, C. J. (2023). Implementing an evidence-based prize contingency management protocol for stimulant use disorders. Journal of Substance Abuse Treatment.U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. (2024, November 7). Contingency management for the treatment of substance use disorders: Enhancing access, quality, and program integrity for an evidence-based intervention (Report to Congress). U.S. Department of Health and Human Services.National Institute on Drug Abuse. (2018). Principles of drug addiction treatment: A research-based guide (3rd ed.). National Institutes of Health.Major, E., Blake, E., Bass, R., Galvin, A., Crowder, T., & Ramage, M. (2023). Contingency management in a perinatal substance exposure clinic. The American Journal of Accountable Care, 11(2), 16-21. https://doi.org/10.37765/ajac.2023.89380We would love your feedback on our podcast! Please take our listener survey to provide your comments.Music credit: "Carefree" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 Licensehttp://creativecommons.org/licenses/by/4.0/Please provide feedback here:https://redcap.mahec.net/redcap/surveys/?s=XTM8T3RPNK
In 1998, researchers initiated a study off the coast of Miami Beach to evaluate how different construction materials influenced the effectiveness of artificial reefs. Over a three-year period, divers monitored twelve structures built from limestone boulders, concrete-gravel, and a concrete-tire aggregate to compare their impact on marine life. The findings revealed that all three materials supported similar levels of fish abundance, biomass, and species richness, regardless of the specific substance used. While the materials themselves did not create significant variations, the study confirmed that the artificial reefs successfully increased the local marine population compared to the original seabed. Ultimately, the data suggested that environmental factors and seasonal changes played a larger role in fish distribution than the reef's physical composition. This research highlights the viability of using diverse materials, including recycled tire chips, to create productive underwater habitats.https://atlantisseacolony.com/#ArtificialReefs #MiamiBeach #MarineLife #OceanConservation #ReefRestoration #MarineBiology #FishHabitat #RecycledTires #SustainableMaterials #UnderwaterHabitat #CoastalResearch #MarineScience #Biodiversity #OceanStudy #EnvironmentalScience #ReefBuilding #FloridaReefs #MarinePopulation #EcoFriendlyReefs #TireRecycling #HabitatCreation #OceanHabitat #SpeciesRichness #FishAbundance #SeabedRestoration
Die Basler Regierung hat vor fünf Jahren ihr Stadtklimakonzept präsentiert, mit dem sie die Klimaziele 2037 erreichen will. Mit einem Jahr Verspätung kam die Evaluation des Berichts heraus. Fachleute sagen SRF, erreicht sei damit viel zu wenig. Ausserdem Thema: · Liberale in Basel uneinig bei der Anti-Chaoten-Initiative der SVP
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
Send us Fan MailIn the 2027 Physician Fee Schedule, CMS (Centers for Medicare & Medicaid Services) is proposing modifications for procedures and E&M services (Evaluation & Management) performed on the same day. In this episode, Captain Integrity Bob Wade describes what is being proposed as it relates to the Stark Law. Hear what is not going away, why the proposal is a payment methodology proposal, how there's still time for advocacy to take place, several medical & non-medical examples, and Captain Integrity's famous air quotes. Learn more at WadeHealthLaw.com
This podcast was created using NotebookLM.This podcast describes the Community Oral Health Program at the Herman Ostrow School of Dentistry of USC, emphasizing its role in addressing the national shortage of dental professionals.
Target Market Insights: Multifamily Real Estate Marketing Tips
This week, learn how John evaluates the current multifamily market and decides whether to buy, sell, or hold. John opens with the question he hears most often from investors in the current portfolio: what is the outlook, and where does the firm stand as a buyer or a seller today? John explains what has changed. Higher interest rates raised the cost of capital and made it harder to find deals that pencil, while higher savings rates gave investors a low risk alternative that did not exist a few years ago. He walks through the framework he uses in response: separate what you cannot control from what you can, start with operations and the value add upside still available, then weigh that against the runway left on the loan. He also makes the case for thinking like a trader of assets, explains why leverage determines who wins a trade, and shares why he believes multifamily fundamentals remain healthy despite the short term pressure in the market. Make sure to download our free guide, 7 Questions Every Passive Investor Should Ask, here. Key Takeaways Stop spending energy on variables you cannot control Evaluate every deal individually before making portfolio decisions Weigh the value add upside still available against the time left on the loan Never put yourself in a position where you are forced to sell Treat assets as trades and know where your leverage sits Expect forced sellers over the next 12 to 18 months to create buying opportunities Topics What Investors Are Asking Right Now Investors want to know the outlook and whether the firm is buying or selling Most deals in the portfolio are cash flowing, though not at past distribution levels Why the Market Has Changed Higher interest rates raised the cost of capital and thinned the pool of deals that pencil High yield savings accounts now pay a decent return for far less risk Investors are more cautious after deals that did not perform as projected Focus on What You Can Control John tracks the economy, the Treasury, and the value of the dollar without fixating on them Interest rates in 2027 and election driven policy changes sit outside any operator's control Awareness informs the projection; energy goes toward internal execution Operations Come First Every deal gets reviewed individually for performance, cash flow, and remaining upside If rents can still be pushed and demand is strong, keep executing the business plan Once the value add is captured, the deal moves into a second phase Loan Term Drives the Exit Decision A short runway with the value already captured points toward selling sooner A longer runway with upside remaining supports holding the asset Most deals fall between those two cases and require weighing both factors Selling on Your Terms John is a seller at the right price but wants to stay in control of the timing He expects some operators to be forced to sell over the next 12 to 18 months Groups already exiting at a loss will create opportunities for prepared buyers Why Multifamily Fundamentals Remain Healthy Population growth and the housing shortage have not gone away New construction starts have tapered off after several heavy supply years Midwest markets such as Cincinnati saw smaller swings in both directions The Trade Mindset Brokers talk about assets trading, and John applies the same framing as an investor The mindset centers on a clear business plan and a defined exit instead of an indefinite hold John compares the approach to running a sports team as a general manager Leverage Wins Trades Owning an asset other buyers want is what creates leverage Anyone forced to offload a deal rarely gets the number they wanted Positioning for competition, demand, and a strong story protects value at exit Reading Market Sentiment What buyers are willing to pay matters more than John's own view of value The firm buys when the business plan works and the price makes sense Evaluation is continuous, not a position set in stone
Iron deficiency anemia is one of the most common nutritional deficiencies in children and adolescents, but it can sometimes be easy to miss. From the toddler who drinks almost exclusively milk to the adolescent athlete struggling to keep up with their peers or the teen with heavy menstrual bleeding and persistent fatigue, these patients may present differently while sharing the same underlying diagnosis. In this episode, we explore iron deficiency anemia in pediatric patients, including why it remains so common, which children and adolescents may be at increased risk, and the clinical clues that can help pediatricians recognize iron deficiency before it becomes a missed opportunity. Joining us for this important conversation is Akhila Vadivelan, MD, a pediatric hematologist/oncologist at Children's Hospital Colorado and an assistant professor at the University of Colorado School of Medicine. Some highlights from this episode include: Evaluation, diagnosis and management of iron deficiency anemia What this diagnosis means for different populations Clinical clues pediatricians should look out for When treatment makes sense For more information on Children's Colorado, visit: childrenscolorado.org.
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers homelessness and mental illness with Dr. Vicky Stergiopoulos, senior scientist with the General Adult Psychiatry and Health Systems Division at the Centre for Addiction and Mental Health (CAMH). She is also a full professor in the Department of Psychiatry and the Institute of Health Policy, Management and Evaluation at the University of Toronto.She has served in several administrative roles, including vice-chair, clinical and innovation (2017-2022) and co-Director of the Division of Adult Psychiatry and Health Systems (2012-2017) in the Department of Psychiatry, as well as physician-in-chief at the Centre for Addiction and Mental Health (2016-2022), psychiatrist-in-chief at St. Michael's Hospital (2011-2016) and medical director, Inner City Health Associates (2017-2011).Dr. Stergiopoulos completed her medical training at Dalhousie University and residency training in psychiatry at the University of Toronto. She holds a MHSc in health administration from the University of Toronto's Institute for Health Policy, Management and Evaluation and completed director's education training at the Rotman School of Management. The learning objectives for this episode are as follows:Define homelessness and housing insecurity and identify key social determinants that shape health outcomes in this populationUnderstand how homelessness intersects with mental health, substance use, trauma, and barriers to care and recoveryEvaluate clinical and systems-level approaches to improving care in the interdisciplinary practice and trainingGuest: Dr. Vicky StergiopoulosHosts: Dr. Sena Gok, Dr. Matthew Cho (PGY2), Dr. Angad Singh (PGY3), Dr. Sophie Gregoire-Mitha (PGY2)Audio editing by: Dr. Sena Gok
This special edition focuses on my evaluation of 4 football games, during Week 1 of the 2026 season. This episode is an experiment. If popular there will be more evaluations of upcoming games in the weeks ahead. Respectfully, Len (Coach Sam) Samborowski
Show SummaryOn today's episode, we're having a conversation with Registered Nurse, Military Spouse, and Workforce Development Advocate Tracy Steele, founder of Community Cultivator, an organization dedicated to strengthening well-being, belonging, and career stability for military spouses through community connection and professional developmentEpisode Partner:Our sponsor this week is Aetna, a trusted health care company, committed to serving Veterans, military families, and caregivers through meaningful, community-centered care. Provide FeedbackAs a dedicated member of the audience, we would like to hear from you. If you PsychArmor has helped you learn, grow, and support those who've served and those who care for them, we would appreciate hearing your story. Please follow this link to share how PsychArmor has helped you in your service journey Share PsychArmor StoriesAbout Today's GuestCommunity Cultivator was founded by Tracy Steele, SPHR, CPRW — a longtime military spouse, workforce development leader, and advocate for military spouse employment and community connection.After more than two decades navigating military life, Tracy experienced firsthand the challenge of constantly rebuilding career momentum, professional networks, and community with every move. Through strategic volunteering, networking, and workforce development leadership, she became passionate about helping military spouses recognize their value and confidently pursue meaningful opportunities.But she realized military spouses needed more than job resources alone. They needed connection, belonging, and access to opportunities that could grow with them wherever military life led next.So she built Community Cultivator.What started as a vision in San Diego is growing into a nationwide movement helping military spouses build stronger careers, deeper connections, and lasting opportunities together.Links Mentioned During the EpisodeCommunity Cultivator WebsiteForeign Born Military Spouse NetworkSugar Bear Foundation WebsitePsychArmor Resource of the WeekThis week's PsychArmor Resource of the Week is the PsychArmor course 15 Reasons to Hire a Military Spouse. As an employer, you are looking for untapped talent pools. One talent pool that can be overlooked is the diverse and highly educated group of military spouses. Take this course to learn the top 15 Reasons to Hire a Military Spouse. You can find the resource here: https://learn.psycharmor.org/courses/15-Reasons-to-Hire-a-Military-Spouse Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on XPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families. You can find more about the work that he is doing at www.veteranmentalhealth.com
Ben Symes is back in studio on The Green Scene with David Wilson and Matthew Brennan, and there's plenty to get through as the Nations League returns in the next few weeks.The lads dig into Troy Parrott's early days at Real Betis – from a Seville watchalong to that offside goal, missed chances, and why the signs are still encouraging ahead of Real Madrid and Champions League football.It's a busy round-up of Irish interest too: Jack Moylan's impact for Cardiff, Nathan Collins' latest “heart in mouth” moment for Brentford, and what next for Johnny Kenny on deadline day.Plus, Seamus Coleman and Robbie Brady's free-agent limbo, Ogbene's Lincoln loan, and the FAI push to land Ceadach O'Neill.And as ever, we are looking for your inspiration to help us, fancy getting in touch?You can do so by emailing thegreenscene@offtheball.com Contact us on socials @offtheball across all our platforms.Or if you want to contact us directly message the @offtheball.football account on Instagram.And as ever, we are on WhatsApp on 087 9 180 180.Become a member and sign up at offtheball.com/joinThe Green Scene on Off The Ball with Cadbury, a proud sponsor of the Republic of Ireland football teams.
Like the show? Show your support by using our sponsors.Need to update your shop systems and software? Try Tekmetric HERELaunch your tool game to the next level with Launch Tech USA! HEREIn this episode, Jeff Compton talks with Tanner Waters, a field and shop technician in rural Montana, about his path into the trade and what life is like working on tractors, combines, and hay equipment. Tanner shares his apprenticeship experience, field diagnostics, long drives, and major repairs while comparing hourly efficiency pay with flat rate.The conversation also explores why younger technicians leave the industry, the importance of shop culture and leadership, technician communication, diagnostic time, training apprentices, and the future of agricultural equipment with autonomy, EVs, emissions, and right to repair.Timestamps:00:00 Shop Culture Wins 00:34 Podcast Intro and Guest Setup 01:45 Montana Life and Fishing Talk 02:43 How Tanner Got Wrenching 03:24 Corvette and Hemi Memories 05:43 Wrangler Ownership and Oil Cooler 08:41 Life as a Field Tech 11:55 Winter Regens and Emissions 13:36 From Kenworth to John Deere 14:32 Old-School Trucks and Cabovers 18:17 Apprenticeship Tools and Toolboxes 22:50 Princess Auto and Canada Road Trip 26:14 MMA Stories 31:02 The Missing Age Group in the Trade 32:00 The Flat Rate Gap 34:48 Recalls and PIPs 36:08 Why Technicians Leave 40:54 Hourly Efficiency Pay 51:18 Workflow Support Roles 55:03 Technicians Selling the Job 59:54 Pre-Authorizing Repairs 01:04:18 Why Diagnostics Take Time 01:09:50 Transmission Service Expectations 01:11:05 Free Diagnostics vs. Evaluation 01:13:08 Asking Better Questions 01:14:07 Intermittent Turbo Faults 01:15:19 Parts Quality Reality Check 01:18:39 Build Quality and Technician Pay 01:20:54 Training Apprentices the Right Way 01:23:27 Motivation and Career Paths 01:27:13 Turnover and Leadership 01:32:56 Ag Tech Levels and Certifications 01:34:08 Autonomy and Electric Agriculture 01:38:29 EVs in Rural Life 01:41:32 Muscle Cars and Collectors 01:44:49 Jeep Ducks Culture 01:45:53 The Top-Off Jeep Debate 01:47:13 Wrangler Tops and Leaks 01:48:26 Refrigerant Changes and 1234yf 01:49:58 AC Repair Customer Headaches 01:52:57 DIY Refrigerant Cans and Regulations 01:57:29 Right to Repair Deere 02:01:26 Technician Shortage and OTA Updates 02:04:36 Self-Driving and Subscriptions 02:08:54 Shop Culture and Career 02:13:35 Events, Sponsors, and Farewell Follow/Subscribe to the show on social media! TikTok - https://www.tiktok.com/@jeffcompton7YouTube - https://www.youtube.com/@TheJadedMechanicFacebook - https://www.facebook.com/profile.php?id=100091347564232
Contributor: Aaron Lessen, MD Educational Pearls: Blunt cerebrovascular injury (BCVI) BCVI is a traumatic injury to the carotid or vertebral arteries Patients may initially have no neurologic symptoms In some cases, a thrombus can form at the site of the injury and later cause ischemic stroke, sometimes hours after the original trauma CT angiography (CTA) of the neck is a useful screening tool for BCVI HIstorically, CTA was reserved for patients with high-risk mechanisms or neurologic symptoms CTA screening has expanded as understanding of BCVIs and their prevention progresses The Denver criteria were developed to identify patients with increased risk for BCVI High-risk findings include cervical spine injuries and severe facial or skull-base fractures Screening practices still vary between trauma centers, though expansion of proactive CTA is an increasingly common practice References Kim DY, et al. Evaluation and management of blunt cerebrovascular injury: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020. Biffl WL, et al. Screening for and treatment of blunt cerebrovascular injuries: Western Trauma Association critical decisions algorithm. J Trauma. 2009. Brommeland T, et al. Best practice guidelines for blunt cerebrovascular injury. Scand J Trauma Resusc Emerg Med. 2018. Harper PR, et al. Routine CTA screening identifies blunt cerebrovascular injuries missed by clinical risk factors. Trauma Surg Acute Care Open. 2022. Summarized by Sam Pahl | Edited by Sam Pahl & Ahmed Abdel-Hafiz, NREMT-P Donate: https://emergencymedicalminute.org/donate/ Join our mailing list: http://eepurl.com/c9ouHf
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
New research reveals a specific vulnerability window during pregnancy when cell phone radiation may trigger lasting brain damage in developing babies. In this episode, I walk through a groundbreaking study that exposed pregnant rats to nine hundred megahertz EMF radiation -- the same frequency range as cell phones -- during different stages of pregnancy. The findings reveal that timing matters enormously: exposure during late pregnancy caused severe brain cell death in offspring, while early pregnancy exposure showed no damage. I explain the specific molecular mechanisms involved and what this means for pregnant women today. In This Episode Why gestational timing determines EMF brain damage severity The two proteins that signal cell phone radiation-induced brain cell death Which brain cells are most vulnerable during development Practical steps pregnant women can take starting today Featured Study Read the full study: An Evaluation of Neuronal PARP-1 and Caspase-3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages See all studies at shieldyourbody.com/research
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
Drive with Dr. Peter Attia: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter sits down with Dr. Linus Abrams, a psychiatrist with nearly 35 years of clinical experience specializing in mood disorders and psychopharmacology, to explore how our understanding of mental health is evolving beyond the traditional neurotransmitter model. After decades in practice, Linus began questioning many of the assumptions underlying modern psychiatry, leading him to investigate how hormones, metabolism, inflammation, circadian biology, and the endocrine system shape mood and cognition. Together, Peter and Linus examine why psychiatric care should aim not only to reduce symptoms but also to restore the full human experience. They discuss how psychiatric medications work, where they fall short, and why distinguishing bipolar disorder from unipolar depression is essential for effective treatment. The conversation also explores the growing mental health burden of social isolationn associated with digital devices and social media, along with the biological factors—nutrition, exercise, sleep, and chronic stress—that influence resilience and distress tolerance. Linus explains the powerful roles of estrogen, progesterone, testosterone, and thyroid hormone in regulating mood and cognition across the lifespan. Finally, Peter and Linus review the promise and limitations of ketamine and psychedelic therapies, and why the future of psychiatry may lie in integrating neuroscience, endocrinology, and whole-body physiology to better understand, diagnose, and treat mental illness. We discuss: Linus's passion for understanding his patients and going beyond traditional psychiatry [2:45]; A short primer on the different classes of drugs used in psychiatry [12:45]; Evaluation of a patient with bipolar disorder [26:00]; An evolutionary perspective on depression [33:30]; Changes in the modern world triggering mental health problems [41:00]; An evolutionary perspective on insomnia [48:15]; Peter's window analogy to understand distress tolerance and irritability [49:45]; The impact of foundational biological factors on psychiatry: nutrition, exercise, sleep, and endocrinology [52:30]; The effect of estradiol on neurotransmitters in the brain [58:15]; Options for increasing testosterone in men, and why clomiphene is inferior to exogenous testosterone [1:11:00]; The rapid drop in progesterone is linked to both premenstrual dysphoric disorder (PMDD) and postpartum depression [1:14:30]; Treatment of postpartum depression [1:18:00]; Hypothyroidism presenting as depression: how Linus makes the diagnosis and what he uses for treatment [1:26:00]; The link between hyperarousal and chronically elevated cortisol [1:39:30]; A case where the menopause transition uncovers bipolar disorder [1:44:15]; Ketamine as a tool to treat recalcitrant depression, and concerns about its recreational use [1:49:15]; Case study: an Alzheimer's patient who improved after psilocybin, and why Linus is cautious about drawing conclusions from it [1:55:15]; Peter's experience with psychedelics, and the myth that estrogen is bad for men [2:00:30]; The therapeutic potential of psychedelics in psychiatry [2:11:00]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube
Cardiovascular disease remains a leading and preventable contributor to maternal death, and women with the highest-risk heart conditions can face maternal morbidity rates approaching 50%. In this vodcast, learn how to support patients with preexisting heart disease through every stage of the reproductive journey, from preconception counseling to postpartum care. This session highlights risk stratification, collaborative care planning, and evidence-based strategies to improve maternal and fetal health outcomes. For more professional resources on maternal health, please visit professional.heart.org/maternal-health.
In this week's episode your fave death divas are back to talk about a shocking funeral home scandal! But first, listen in as Madison tells us some incredible survivor stories. We've got an obituary for a loopy guy, one for an American icon and so much more! Including….drum roll please….some DUMB ASS CRIMINALLLLLLLLLLLLLS! LET'S GO! Please rate and review wherever you listen! Watch us on YouTube: Youtube.com/@obitchuarypodcast Buy our book: prh.com/obitchuary Come see us live on tour: obitchuarypodcast.com Join our Patreon: Patreon.com/cultliter Follow along online: @obitchuarypod on Twitter & Instagram @obitchuarypodcast on TikTok Check out Spencer's other podcast Cult Liter wherever you're listening! Sources: https://nypost.com/2026/07/30/us-news/heavily-intoxicated-cruise-passenger-accused-of-beating-up-kids-playing-tag/ https://www.butlermemorials.com/obituaries/vander-june-huffman https://www.wbko.com/2026/01/15/metcalfe-county-couple-found-dead-after-shooting-ksp-says/ https://www.facebook.com/EricHorngABC7/videos/woman-who-held-mothers-homegoing-at-funeral-home-where-decomposing-bodies-found-/1573637084398036/ https://www.cbsnews.com/chicago/news/south-side-funeral-homes-license-suspended-over-decomposing-bodies-and-deplorable-conditions/ https://www.cbsnews.com/chicago/news/bodies-found-decomposing-chicago-funeral-home-families/ https://www.cbsnews.com/chicago/news/south-chicago-chapel-bodies-found-investigation-state-regulators/ https://abc7chicago.com/post/lawsuit-filed-south-chicago-chapel-funeral-home-95th-street-accused-mishandling-dozens-bodies-human-remains/19669605/ https://www.nytimes.com/2026/08/10/us/jackie-bald-eagle-california-dead.html https://www.timesunion.com/news/article/peter-porco-s-death-detailed-580264.php https://en.wikipedia.org/wiki/Murder_of_Peter_Porco https://www.youtube.com/watch?v=8Pc8B9PQ0To https://www.academia.edu/59335906/Evaluation_of_survival_time_and_acting_capability_after_fatal_injuries_based_on_the_type_and_extent_of_injuries https://www.sciencedirect.com/science/article/abs/pii/S0379073813004039 https://www.bbc.com/news/health-12649555 https://www.newspapers.com/image/915900769/?match=3&terms=peter%20porco&search-id=ba1f5f7f-0ad0-4291-b5d5-4b7baf591d06&search-rank=3 https://www.indiatoday.in/fyi/story/man-did-his-daily-chores-until-his-last-breath-porco-case-man-died-325962-2016-05-27 https://www.smithsonianmag.com/history/phineas-gage-neurosciences-most-famous-patient-11390067/ https://en.wikipedia.org/wiki/Phineas_Gage https://pmc.ncbi.nlm.nih.gov/articles/PMC1114479/ https://en.wikipedia.org/wiki/Leroy_Petry https://www.fox13news.com/news/video-florida-man-accused-driving-110-mph-claimed-he-was-speeding-catch-his-cheating-girlfriend Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
In part one of our conversation with John Godlove and Piyush Agarwal, co-founders of Fusion Hive, we talked about starting with the workflow instead of the AI. Before choosing a model or building an agent, you need to understand the problem. You also need to understand the process, the data, and what you're trying to improve. In part two, we took that conversation further. We looked at what happens when you move from an AI demo into something a business actually depends on. That's when governance, data privacy, testing, guardrails, monitoring, and cost become much more important. Piyush made a comment that sums this up well. If your workflow is already broken and you throw AI at it, you're probably going to accelerate the chaos. About John Godlove and Piyush Agarwal John Godlove is co-founder of Fusion Hive and has more than a decade of experience helping organizations from startups to Fortune 500 companies build and deploy automation. His background includes work in the Salesforce ecosystem, AI, data, and technology implementation. Piyush Agarwal is co-founder of Fusion Hive and has more than a decade of experience in artificial intelligence and machine learning. His experience includes financial fraud detection, document intelligence pipelines, generative AI multi-agent architectures, and production machine-learning engineering. Together, John and Piyush founded Fusion Hive to bring enterprise AI and automation experience to small and mid-market businesses. Their approach focuses on practical workflows, measurable outcomes, governance, and production-ready AI systems. AI Has a Way of Exposing Problems You Already Had We've been talking all season about AI exposing the cracks in businesses and software development. This conversation was a great example of what we mean. Many businesses don't have perfectly documented processes. The official procedure may say one thing, while the person doing the job follows a slightly different process because they know what works. Sometimes that critical business knowledge isn't documented anywhere. It may be sitting in someone's head, buried in an email, or handled through an informal process. Humans are pretty good at filling in those blanks and making judgment calls. Software needs us to be much clearer about the rules. John explained that small and mid-market businesses don't always have mature governance structures. Regulated organizations tend to have more structure because regulations require it. Other companies may not discover these governance problems until they start looking seriously at AI. The AI project doesn't necessarily create the crack. It often shines a light on something that was already there. That can actually be a good thing. An AI project may force you to understand how your business really works. It can push you to document processes, identify ownership, and clean up your data. You may get significant value from that work before the first AI workflow ever reaches production. AI Governance Is Bigger Than AI When I asked John and Piyush about governance and protecting customer data, one thing became pretty clear. You can't treat AI governance as something that exists by itself. Your business already has systems, users, data, security policies, vendors, and access controls. The AI system has to live inside that environment. Piyush explained that Fusion Hive tries to work within the systems a customer already uses. They don't automatically introduce another platform. A business may already be heavily invested in Microsoft, Google, Azure, AWS, or another ecosystem. Those existing systems may already provide infrastructure that can support the new workflow. John added that internal IT departments and managed service providers also need to be part of the conversation. AI governance overlaps with data governance, cybersecurity, access controls, and existing policies. You can't build one without considering the others. I think that's an important way to look at this. AI may feel like an entirely new technology problem, but it's still another component in your business systems. You still need to know who can access information, where that information goes, and who owns the process when something fails. Know Where Your Data Is Going Data privacy becomes even more important once AI enters the conversation. Before connecting business information to a model, find out where that data goes and what happens to it. Does the provider retain it? Can the provider use it for model training? Does the platform provide the protections your business needs? Those questions become critical in healthcare, financial services, and other regulated environments. Piyush talked about cases where businesses may need specific configurations or agreements with providers. These protections can prevent providers from using company data for model training. He also pointed out that not every use case requires a frontier model. A smaller or open model may work for some problems. That option may also give the business more control over where and how it processes information. The exact solution depends on the business. The important thing is to ask these questions before implementation. You don't want to connect company data to an AI system and then ask where that information went. The Wrong Use Case Can Make AI Expensive Fast When I asked John and Piyush about mistakes they've seen businesses make with AI, John's answer wasn't some crazy technical failure. One of the biggest mistakes is simply choosing the wrong use case. A business leader hears that the company needs AI. Somebody gets a directive to "get AI live," and the team builds something impressive for a demo. But nobody defines what business metric the project should improve. John suggested working backward from the business outcome. Maybe you want to improve margins or reduce turnaround time. Maybe you want to shorten lead qualification or improve the lead-to-cash process. Once you know the target, you can trace that goal back to the workflows that influence it. This is where I think many AI projects can get into trouble. "We implemented AI" isn't a business result. If you don't know what you're trying to change, you may spend money without knowing whether the investment helped. You Need a Baseline Before You Can Measure ROI Of course, that creates another problem. Some businesses don't know how their existing processes perform today. They know people are busy and a workflow feels slow. But they haven't measured the time, exceptions, rework, or actual cost. John talked about measurements such as cycle time, quote turnaround, lead qualification, and lead-to-cash timing. Those numbers give you something to compare after you introduce automation. If a process took 40 hours before AI and takes 20 afterward, you have a measurable improvement. The same applies if errors drop or turnaround improves. Without a baseline, you're guessing. Six months later, you might have a cool AI system. But when somebody asks what it saved the company, the answer can't just be that everyone seems to like it. Don't Automate a Broken Process This is where Piyush made one of the strongest points of the interview. If the workflow is already broken, AI will accelerate whatever already exists. That includes the chaos. Bad data doesn't suddenly become good because an LLM reads it. Unclear ownership doesn't disappear because an agent performs the task. If nobody can tell you whether the result is correct, you're probably not ready to hand that process over to AI. Before you automate, you may need to clean the data or document the rules. You may need to fix the process or determine who owns the outcome. That work can slow down an AI project at the beginning, but I'd rather find those problems before production than after. This reminds me of what we see in testing and automation. Automating a bad test or a bad process doesn't make it better. It just lets you run the wrong thing faster and more often. AI gives us more capability, but that basic engineering principle hasn't changed. Evaluation, Guardrails, and Monitoring This was probably my favorite technical part of the conversation because it lines up with my testing and integration background. Piyush identified three areas that matter when moving an AI workflow toward production: Evaluation Guardrails Monitoring Before production, you need to evaluate the workflow against known data. Piyush described maintaining a holdout or "golden" dataset with known expected results. You can run the workflow against that data and check whether the system produces acceptable results. For developers and testers, this should sound familiar. We've been doing versions of this forever. Give the system a known input, define the expected output, run the test, and compare the results. AI changes how predictable some outputs may be. It doesn't remove the need to test them. In fact, I think AI's variability makes evaluation even more important. Put Guardrails Around What AI Can Do Testing the output is only part of the problem. Once an AI system can take actions, you need to decide what it's allowed to do. We've already seen examples of public-facing AI systems producing ridiculous results because nobody properly constrained them. Guardrails should define where the AI has authority and what requires validation. They should also define when the system needs to stop and ask for help. Some decisions may require deterministic rules, while others may need human approval. This is another place where I don't think we should look at the problem as AI versus humans. A better solution may combine AI, deterministic software, validation rules, and people. Give each part of the system the job it's actually good at. Deployment Isn't the Finish Line Piyush's third piece was monitoring. I think this will become increasingly important as more companies put AI into production. You don't test the system once, deploy it, and forget about it. You need to watch what happens after release. What questions are users asking? What does the system return? What new exceptions appear? Where does it get confused? Those production interactions can become part of the feedback loop that improves the system. That's not very different from what we've learned from building software for years. Production teaches you things your test environment never will. AI can make the behavior less predictable, which makes monitoring and ownership even more important. Don't Forget the People Using the System You can choose the right use case, design the right architecture, and test everything correctly. The implementation can still fail if nobody uses it. John talked about enablement and training as a critical part of the rollout. This becomes especially important when AI changes an existing business process. Employees need to understand what changed, how to use the new system, and why the organization made the change. You also need to deal with the obvious concern that employees may think AI is there to replace them. If that's what people believe, don't be surprised when adoption becomes difficult. We've dealt with change management in software projects forever. AI hasn't removed the human side of implementation. The Most Powerful Model Isn't Always the Right Model Our bonus conversation moved into another area that more businesses are starting to discover: running AI in production can get expensive. Most people first experience AI through ChatGPT, Claude, Copilot, or another chat interface. Production workflows can look very different. An agent might ingest emails, read PDFs, extract information, transcribe documents, and call other systems. Now imagine doing that thousands of times. John explained that businesses need to understand these cost drivers because AI expenses can vary much more than a traditional monthly SaaS bill. Piyush made another good point here. The biggest and most capable model isn't automatically the right model for every task. If you're doing a simple email summary, do you really need the most expensive frontier model available? Probably not. Route the Work to the Right Tool This brought us back to something we discussed in part one. Sometimes the right solution isn't AI at all. Piyush described task-based routing, where the system decides what capability a particular task needs. A simple request might go to a smaller model. A complex reasoning problem could go to a more capable model. A deterministic task might go directly to traditional code. This approach can improve cost, speed, and predictability. John also talked about making systems LLM agnostic. You don't want to lock an entire business process into whichever model happens to be popular today. This market moves incredibly fast, and today's best choice may not be the best choice a year from now. That's more than a technical architecture decision. If you're building something the business expects to run for years, you need to think about changes in pricing, vendors, and technology. Build for the Business, Not the AI Trend The biggest thing I took away from this second part of our conversation is that successful AI implementation looks a lot like good engineering. Understand the problem, know where your data comes from, establish ownership, and define the expected outcome. Then test the system, add controls, monitor production, and make sure the people using it understand the change. AI gives us some incredible new capabilities, but it doesn't make those fundamentals disappear. If anything, it makes the cracks more obvious when we skip them. Before you automate that next process, take a hard look at what you're actually automating. If the process is broken, the data is bad, nobody owns the outcome, and you can't measure success, AI probably isn't your first problem. Otherwise, you may not be automating your business. You may just be automating the chaos. Stay Connected: Join the Developreneur Community
Show SummaryOn today's episode, we're having a conversation with Navy Veteran Dr. Erik Won, President and Chief Medical Officer of Wave Neuroscience, an organization utilizing advanced neuroimaging and magnetic resonance therapy to help veterans recover from post-traumatic stress. DisclaimerThis podcast is for informational and educational purposes only and does not establish a doctor-patient relationship. The views and opinions expressed by the guest are entirely his own and do not reflect the views, policies, or official positions of his employer or company. Content is not intended to substitute for professional medical advice, diagnosis, or treatment. Wave supplies MeRT to licensed clinics who provide treatment to patients. Talk to your physician to see if MeRT is right for you. Episode Partner:Our sponsor this week is Aetna, a trusted health care company, committed to serving Veterans, military families, and caregivers through meaningful, community-centered care. Provide FeedbackAs a dedicated member of the audience, we would like to hear from you. If you PsychArmor has helped you learn, grow, and support those who've served and those who care for them, we would appreciate hearing your story. Please follow this link to share how PsychArmor has helped you in your service journey Share PsychArmor StoriesAbout Today's GuestDr. Erik Won is President and Chief Medical Officer of Wave Neuroscience, Inc; a biotechnology company that has innovated breakthrough technologies called Magnetic e-Resonance Therapy (MeRT) and Synchronized Transcranial Magnetic Stimulation (sTMS). MeRT recently received FDA Breakthrough Technology designation and FDA clearance for Post-Traumatic Stress Disorders. These approaches utilize computational neuroanalytics and brain imaging to customize treatment protocols with the aim of restoring optimal neurological function.These modalities represent a form of precision-guided medicine that has been researched or is currently being used by premier institutions such as US Special Operations Command, Stanford University School of Medicine, Duke University - Human Performance Opti-Lab, University of Southern California (USC) Center for Neurorestoration, the University of California Los Angeles (UCLA) - David Geffen School of Medicine, University of Pennsylvania, Brown University, Air Force Research Laboratory, and the Texas A&M Institute for Bioscience and Technology.Erik joined Wave Neuroscience after serving as the Chief Physician and Chief Technology Officer (Health Services) for the Boeing Company. He also served as a US Navy Flight Surgeon for Marine Medium Helicopter Squadron 268, and received the distinction of serving as the ACE Flight Surgeon for the 11th Marine Expeditionary Unit, 1st Marine Expeditionary Force. Dr. Won has been published in numerous peer-reviewed journals, textbooks, and presented in numerous academic conferences. He completed his residency at the Harvard OEM combined residency program and was appointed Chief Resident. He received a Masters in Public Health (MPH) from the Harvard School of Public Health and Masters in Business Administrations (MBA) from the University of Southern California, Marshall School of BusinessLinks Mentioned During the EpisodeWave Neuroscience WebsiteBrain Treatment Center WebsitePsychArmor Resource of the WeekThis week's PsychArmor Resource of the Week is the PsychArmor course Brain Health & Wellness Learning Series – PTSD. Nearly everyone goes through a traumatic event at least once during their lifetime. Military service members and Veterans are especially vulnerable to the lasting effects of post-traumatic stress due to the nature of their duties and experiences. While this can be a difficult diagnosis to navigate, it is treatable, and social support is one of the leading factors for lasting recovery. Having someone to trust and confide in while feeling heard and validated is a vital part of the healing process. This series on post-traumatic stress disorder explores the presentation and diagnosis of PTSD, its impact on both the Veterans you support and the lives of those around them, and effective treatment modalities, so you'll be better equipped to provide meaningful support. You can find the resource here: https://learn.psycharmor.org/courses/WWP-BHW-PTSD Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on XPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families. You can find more about the work that he is doing at www.veteranmentalhealth.com
John Shea of the San Francisco Standard speaks to the Giants' roster churn as the team looks nearly unrecognizable, plus we discuss Rafi Devers' role as a mentor, if not a leader, on the 2026 team with key players injured. See omnystudio.com/listener for privacy information.
Mike Schaefer and Mike'l Severe discuss the portal before diving into how Nebraska has historically evaluate talent.
Once your PERT is assembled, how do you navigate the evolving pulmonary embolism (PE) literature to improve patient outcomes at all risk levels? In this episode of the BackTable Podcast, interventional radiologist Dr. Robert Lookstein (Mount Sinai) and pulmonary critical care specialist Dr. Timothy Fernandes (UC San Diego) join host Dr. Harris Chengazi to examine the latest evidence and multidisciplinary strategies for managing acute pulmonary embolism. The discussion highlights the complexities of catheter-directed therapies in intermediate- to high-risk PE, evolving guidelines in the face of new trial data, and prioritization of improving patients' clinical trajectories. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction03:57 - PERT Structure and Activation08:24 - PE Risk Stratification Tools12:02 - Patient Selection for IR Intervention15:21 - Assessing Clot Chronicity21:03 - Standardizing Workup26:38 - Managing Unstable PE28:31 - STORM-PE and HI-PEITHO Trial Data35:49 - Guidelines vs. New Evidence40:12 - Determining Therapeutic Endpoints45:05 - Upcoming Trials and Future Directions51:46 - Final Thoughts and Closing Remarks --- More about this episode The physicians explore the nuances of validated PE risk stratification tools, assessing the relationship between various PE scoring systems and the 2026 ACC/AHA classification for acute PE. They emphasize that the integration of clinical assessment, serial lab work, and patient history must take precedence over static imaging alone in guiding care. The doctors go on to review new trial data, including the improved RV-to-LV ratio and 90-day functional gains seen with mechanical thrombectomy in STORM-PE and reduced clinical deterioration observed with ultrasound-assisted catheter-directed thrombolysis in HI-PEITHO. The conversation concludes with a call for collaborative, safety-first management that focuses on the patient's clinical status and long-term post-PE functional recovery. --- Resources 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adultshttps://doi.org/10.1161/CIR.0000000000001415 Composite Pulmonary Embolism Shock (CPES) Scorehttps://doi.org/10.1161/CIRCINTERVENTIONS.124.014088 FOCUS studyhttps://doi.org/10.1093/eurheartj/ehac206 STORM-PE trialhttps://doi.org/10.1161/CIRCULATIONAHA.125.077232 HI-PEITHO trialhttps://doi.org/10.1056/nejmoa2516567 PE-TRACT studyhttps://petractstudy.org/homepage PEERLESS II studyhttps://clinicaltrials.gov/study/NCT06055920 PERSEVERE trialhttps://clinicaltrials.gov/study/NCT06588634 --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
We've got our resident M&E expert back on the podcast to talk with us about the value and function of DMEAL in working on grants and of course in program development. In this episode, Brandon Stiver is joined by Jeremy Macias to discuss the importance of monitoring and evaluation in nonprofit work, including the differences in international and domestic contexts. They explore how data-driven practices enhance program effectiveness, build donor trust, and foster continuous improvement in serving vulnerable populations. Lastly, they talk about the role of grad programs in developing humanitarian professionals suited to the needs of the global poor. Podcast Sponsors Are you ready to take your impact to the next level? Then join this year's OneAccord conference October 13th-15th in Washington, D.C.! Use Code "Global" for Discount Register for OneAccord 2026 The MA in Global Development and Justice at Multnomah Seminary (part of Jessup University) is a fully online, accredited graduate program designed for practitioners and advocates seeking meaningful, sustainable change in today's world. Learn More About MAGDJ Resources and Links From The Show Check out the Earthkeepers Podcast Conversation Notes (AI Generated) 02:23 Funding Streams for Nonprofits: Grants, Donations, and Earned Income 04:19 The Role of Monitoring in Grant Proposals and Program Impact 07:13 Building Robust Monitoring Systems in Domestic and International Contexts 12:18 Differences Between US Domestic and International Development Monitoring 17:16 Integrating Monitoring and Evaluation into Program Design 21:09 Using Data to Redesign and Improve Programs 25:20 Case Study: Hopewalks and Clubfoot Program Evaluation 30:05 The Impact of Faith and Theology on Development Practice 34:10 The Value of Continuous Learning and Professional Development Theme music Kirk Osamayo. Free Music Archive, CC BY License
Rushed methodology changes implemented mid-season by Nielsen have severely shaken the NFL's confidence in standard television ratings. NFL Chief Data Officer Paul Ballew explains how media fragmentation is forcing leagues and networks to demand radical transparency or switch to new transactional metrics. Key Highlights
In our fourth Summer School episode this season, hosts Dr. Amber Hildreth and Dr. Jordan Whatley have taken highlights from past episodes on liver disease and put them into a special episode full of clinical pearls.Former expert guests Dr. Bill Balistreri, Dr. Jorge Bezerra, Dr. Saul Karpen, Dr. Dennis Black, Dr. Amy Taylor and Dr. Rohit Kohli cover neonatal cholestasis, biliary atresia, PSC, AIH, and MASLD.Our Bowel Sounds Summer School series will include four episodes each summer on big topics in our field, artisanally crafted for the ears of learners of all stages from the young student to the seasoned attending.Learning Objectives:Understand the evaluation of neonatal cholestasisReview the natural history of PSCReview the diagnosis and management of AIHUnderstand the diagnostic evaluation and management of MASLD.Featured episodes:1. Bill Balistreri- Neonatal Cholestasis2. Jorge Bezerra- Advances in Biliary Atresia3. Saul Karpen- Updates in Biliary Atresia4. Dennis Black- Primary Sclerosing Cholangitis5. Amy Taylor- Autoimmune Hepatitis Management6. Rohit Kohli- Fatty Liver DiseaseAdditional Links:1. Guideline for the Evaluation of Cholestatic Infants2. AASLD PSC Guidelines3. AASLD AIH GuidelinesSend us Fan MailSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.
Original Air Date: April 9th, 2026 During the Pentagon press briefing alongside Joint Chiefs Chairman Gen. Dan Caine, Defense Secretary Pete Hegseth described the two-week ceasefire with Iran as the result of a decisive U.S. military campaign. He stated, “Operation Epic Fury was a historic and overwhelming victory on the battlefield — a capital-V military victory,” claiming it decimated Iran's missile program, navy, and defense industry, rendering its military “combat-ineffective for years to come.” Hegseth added that “Iran begged for this ceasefire, and we all know it,” asserting the regime was “out of options and out of time.” He emphasized that U.S. forces are “not going anywhere,” saying “we'll be hanging around” in the region to monitor compliance, ensure that Iran never acquires a nuclear weapon, and remain “prepared to defend, prepared to go on offense,” and “restart at a moment's notice” if the truce fails. Hegseth noted that “it takes time sometimes for ceasefires to take hold” and framed the pause as giving “a chance at real peace and a real deal,” while praising President Trump for choosing “mercy” instead of further crippling Iran's economy. We also cover: • RFK Jr. is joining the podcasting world. • Jennifer Newsom is trying to be first lady. • New LGBT acronym drops in Canada. • Is the Strait of Hormuz really open? • Buddy the alligator is DEAD! 00:00 Pat Gray UNLEASHED! 00:14 U.S. / Iran Ceasefire 00:36 Strait of Hormuz Closed 01:39 Jeffy Promotes Renewable Energy 03:18 Belgian Foreign Minister in Lebanon 04:31 Pete Hegseth Yesterday 05:55 JD Vance on 10-Point Plan 08:33 JD Vance on Strait of Hormuz 09:26 Price of Oil 12:05 Chuck Schumer Doesn't Like U.S. / Iran Deal 15:47 Karoline Leavitt on U.S. / Iran Deal 17:38 Trump & Karoline Leavitt on NATO 19:00 Do We Need NATO? 20:50 Lawrence O'Donnell is Upset with Pete Hegseth 28:02 Germany Taking Steps with Strait of Hormuz 32:22 Fat Five 43:16 Minnesota Bathhouses 49:14 Blue State Wealth & Exit Taxes 54:24 Jennifer Newsom on Talking to Prisoners 58:20 New Acronym to Memorize 1:07:10 Big Announcement from RFK Jr. 1:10:40 Mike Pence's New Book 1:12:12 Allegations against Eric Swalwell? 1:15:02 Warehouse Fire in California 1:19:46 Evaluation of Iryna Zarutska's Killer 1:21:46 List of Pam Bondi Replacements 1:29:08 Caller Tessa (Pat Gray BINGO! Winner) 1:30:20 "Exspecially" 1:32:07 RFK Jr., Whales, and Bears (Oh My!) 1:32:57 Hasan Piker Feels No Sympathy for U.S. Pilots Learn more about your ad choices. Visit megaphone.fm/adchoices
You read that right, a recipe for Alzheimer's. This week on Schauer Thoughts we're doubling back on a previous episode with some new and very interesting information! Join me on a journey through the body to the brain and out again and please, tip your waiter. “Why is this caption so short?” Because I have limited letter allowance and a lot of sources. 86 that attitude and enjoy! Previous episode I keep referring to: July 22, “The Good, The Bad, the Incredibly Nuanced” https://open.spotify.com/episode/0FrRNutkWpakiUg8i0ANi6 I would strongly prefer you listen to this first. Toxic Thoughts Stand Up Event Link https://www.eventbrite.com/e/toxic-thots-a-queer-comedy-show-tickets-1997497195884?aff=oddtdtcreator Books: A Silent Fire: The Story of Inflammation, Diet & Disease - Shilpa Ravella Loved this book, 10/10. Most of my information on inflammation, LDL cholesterol, fatty acids (long chain vs short chain) and much more I discuss can be found in this book broken down with exquisite detail. The Human Brain Book: A Visual Guide to Structure and Function - Rita Carter Anything I mentioned about brain functioning, signaling, neurotransmitters, olfaction, etc. can be found in this book. I would highly recommend this one if you're looking to learn a lot on the brain. Pg. 204 - the adult brain Pg. 206 - the aging brain Pg. 208 & 209 - Parkinsons, Dementia, & Alzheimer's information Plastic: The Secret History and Shocking Future of Big Oil's Biggest Bet - Beth Gardiner All of the information on the history of plastic, microplastics in the brain and body, as well as petrochemical points are in this book. The Menopause Brain: New Science Empowers Women to Navigate the Pivotal Transition with Knowledge and Confidence - Lisa Mosconi, PhD Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's - Charlies Piller Loving this book so far, it's also great at breaking down the basics of Alzheimer's and treatment directions if you'd like to know more. Sources Online: An Unexpected Way to Upcycle: Plastic Waste Transforms into Soap https://news.vt.edu/articles/2023/08/science-plastics-upcycle-soaps-guiliang-greg-liu.html Scientists Turn One of the World's Hardest-To-Recycle Plastics Into Engine Oil https://scitechdaily.com/scientists-turn-one-of-the-worlds-hardest-to-recycle-plastics-into-engine-oil/ Virginia Tech researcher finds a new method for recycling polystyrene https://news.vt.edu/articles/2022/08/one-industrys-trash-polystyrene.html Developing synthetic polymers to study neurological diseases https://news.vt.edu/videos/k/2023/03/1_u4j8cu1b.html Bioaccumulation of microplastics in decedent human brains https://www.nature.com/articles/s41591-024-03453-1 What does disease smell like? https://www.sciencefocus.com/the-human-body/what-does-disease-smell-like Carvone: One Molecule, Two Different Scents and Flavors https://www.acsh.org/news/2018/08/01/carvone-one-molecule-two-different-scents-and-flavors-13255 Side note, if you're in LA and want to learn more about different scents and how to do scent analysis, I would highly recommend checking out a course at The Institute of Art and Olfaction, I've taken a couple classes there and I loved it. https://artandolfaction.com/ Evaluation of neurobiochemical and behavioral responses to carvone nanoemulsion: A neuroprotective approach for Alzheimer's disease-associated dementia in a rat model https://www.sciencedirect.com/science/article/abs/pii/S0006899326000016 PEG Lipids: Definition, Structure & Key Applications https://www.biochempeg.com/article/429.html Arachnoid Granulation Morphologies Associate with B-Amyloid and Tau Pathology in Older Adults https://pmc.ncbi.nlm.nih.gov/articles/PMC12622154/ Reminder: This is a pre-print! Amyloid, APP, and Electrical Activity of the Brain https://pmc.ncbi.nlm.nih.gov/articles/PMC7222965/ Inhaling high-dose CO2 clears Alzheimer's proteins from the brain https://www.newscientist.com/article/2580471-inhaling-high-dose-co2-clears-alzheimers-proteins-from-the-brain/ Effects of the Percutaneous Carbon Dioxide Therapy on Post-surgical and Post-traumatic Hematoma, Edema, and Pain https://pmc.ncbi.nlm.nih.gov/articles/PMC10753674/ (Orthopaedics) Transcutaneous Carbon Dioxide Treatment is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients https://pmc.ncbi.nlm.nih.gov/articles/PMC6365751/ Please! If you have the time, take a look at this article as well as the reference section, it's such an incredible deep dive. A Common Cholesterol Treatment May Also Remove PFAS and Microplastics from Blood https://www.sciencealert.com/a-common-cholesterol-treatment-may-also-remove-pfas-and-microplastics-from-blood If I missed anything, please let me know and I'll update this list! Learn more about your ad choices. Visit podcastchoices.com/adchoices
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter sits down with Dr. Linus Abrams, a psychiatrist with nearly 35 years of clinical experience specializing in mood disorders and psychopharmacology, to explore how our understanding of mental health is evolving beyond the traditional neurotransmitter model. After decades in practice, Linus began questioning many of the assumptions underlying modern psychiatry, leading him to investigate how hormones, metabolism, inflammation, circadian biology, and the endocrine system shape mood and cognition. Together, Peter and Linus examine why psychiatric care should aim not only to reduce symptoms but also to restore the full human experience. They discuss how psychiatric medications work, where they fall short, and why distinguishing bipolar disorder from unipolar depression is essential for effective treatment. The conversation also explores the growing mental health burden of social isolationn associated with digital devices and social media, along with the biological factors—nutrition, exercise, sleep, and chronic stress—that influence resilience and distress tolerance. Linus explains the powerful roles of estrogen, progesterone, testosterone, and thyroid hormone in regulating mood and cognition across the lifespan. Finally, Peter and Linus review the promise and limitations of ketamine and psychedelic therapies, and why the future of psychiatry may lie in integrating neuroscience, endocrinology, and whole-body physiology to better understand, diagnose, and treat mental illness. We discuss: Linus's passion for understanding his patients and going beyond traditional psychiatry [2:45]; A short primer on the different classes of drugs used in psychiatry [12:45]; Evaluation of a patient with bipolar disorder [26:00]; An evolutionary perspective on depression [33:30]; Changes in the modern world triggering mental health problems [41:00]; An evolutionary perspective on insomnia [48:15]; Peter's window analogy to understand distress tolerance and irritability [49:45]; The impact of foundational biological factors on psychiatry: nutrition, exercise, sleep, and endocrinology [52:30]; The effect of estradiol on neurotransmitters in the brain [58:15]; Options for increasing testosterone in men, and why clomiphene is inferior to exogenous testosterone [1:11:00]; The rapid drop in progesterone is linked to both premenstrual dysphoric disorder (PMDD) and postpartum depression [1:14:30]; Treatment of postpartum depression [1:18:00]; Hypothyroidism presenting as depression: how Linus makes the diagnosis and what he uses for treatment [1:26:00]; The link between hyperarousal and chronically elevated cortisol [1:39:30]; A case where the menopause transition uncovers bipolar disorder [1:44:15]; Ketamine as a tool to treat recalcitrant depression, and concerns about its recreational use [1:49:15]; Case study: an Alzheimer's patient who improved after psilocybin, and why Linus is cautious about drawing conclusions from it [1:55:15]; Peter's experience with psychedelics, and the myth that estrogen is bad for men [2:00:30]; The therapeutic potential of psychedelics in psychiatry [2:11:00]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube
© 2020-2026 Ivy Podcast Discovery LLC
